project id: TCGA-SARC; case submitter id: TCGA-3B-A9HR; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.48; age at index: 38; days to birth: -14041; days to death: 2694; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1969; age at diagnosis: 14041; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2577.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8890/3; primary diagnosis: Leiomyosarcoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: No; tissue or organ of origin: Connective, subcutaneous and other soft tissues of lower limb and hip; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 2404; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-3B-A9HR-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0;